atenolol has been researched along with Brain Inflammation in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichiyama, T | 1 |
| Sakai, T | 1 |
| Catania, A | 1 |
| Barsh, GS | 1 |
| Furukawa, S | 1 |
| Lipton, JM | 1 |
1 other study available for atenolol and Brain Inflammation
| Article | Year |
|---|---|
Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-MSH; Animals; Atenol | 1999 |